Showing results (701-710 of 10,554) with videos related to
Sort By:
Pageof 1,056
Thrombosis Research|February 16, 2000
Differential in vitro effects of the platelet glycoprotein IIb/IIIa inhibitors abixicimab or SR121566A on platelet aggregation, fibrinogen binding and platelet secretory parametersU Klinkhardt, C M Kirchmaier, D Westrup, et al.Thrombosis Research|February 16, 2000
A simple screening assay for certain fibrinolysis parameters (FIPA)T W Stief, F Hinz, J Kurz, et al.Thrombosis Research|December 11, 1999
Effect of X-ray contrast media on blood flow properties after coronary angiographyB Scheller, B Hennen, T Thünenkötter, et al.Thrombosis Research|December 11, 1999
Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolismE Zanon, P Prandoni, F Vianello, et al.Thrombosis Research|July 27, 1999
Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatusA Coiffic, E Cazes, G Janvier, et al.Thrombosis Research|February 19, 2000
Factors affecting the first recurrence of noncardioembolic ischemic strokeT H Wu, H H Chen, T K LeeThrombosis Research|February 19, 2000
Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous bloodG A Kalweit, P Feindt, M Micek, et al.Thrombosis Research|February 19, 2000
Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitusJ P De La Cruz, A Moreno, M I Ruiz-Ruiz, et al.Thrombosis Research|December 11, 1999
Monocyte tissue factor response is decreased in patients with hyperlipidemiaL Rugeri, S Susen, J M Bard, et al.Thrombosis Research|December 11, 1999
The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusionJ Larsson, A HillarpPageof 1,056